HHSIndustrials · ConglomeratesHHS Stock Forecast: Harte-Hanks, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 40 of 100 as at 1 Aug 2026 — in the lower half.
HHS stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Harte-Hanks, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (89): Smaller than most of the companies we track.
Revisions (25): Analysts have, on balance, been cutting their forecasts.
The rank is the raw material. Whether the rules would actually own Harte-Hanks, Inc. — and when they’d sell — is the membership.
HHS stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on HHS, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Nov 2017 | Noble Capital Markets | Upgrade | Buy | — |
| 14 Mar 2016 | BMO Capital | Downgrade | Market Perform | — |
| 8 Dec 2015 | Singular Research | Initiates | Buy | — |
| 21 July 2015 | BMO Capital | Upgrade | Outperform | — |
| 30 May 2014 | BMO Capital | Downgrade | Market Perform | — |
| 21 Oct 2013 | Noble Capital Markets | Downgrade | Hold | — |
| 4 Oct 2013 | BMO Capital | Upgrade | Outperform | — |
| 26 Apr 2013 | Noble Capital Markets | Upgrade | Buy | — |
| 1 Feb 2013 | BMO Capital | Maintains | Market Perform | — |
| 1 Feb 2013 | Noble Capital Markets | Downgrade | Hold | — |
| 26 Oct 2012 | BMO Capital | Maintains | Market Perform | — |
| 26 Oct 2012 | Noble Capital Markets | Upgrade | Buy | — |
| 18 July 2012 | Noble Capital Markets | Downgrade | Hold | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
HHS analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Harte-Hanks, Inc. (HHS) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 2.3×
- Price / sales
- 0.1×
- Price / book
- 0.8×
- EV / EBITDA
- 8.2×
Cheaper than 69% of US stocks
Cheaper than 96% of US stocks
Cheaper than 77% of US stocks
Cheaper than 45% of US stocks
- Revenue growth (YoY)
- −10.3%
- Earnings growth (YoY)
- −10.3%
- Gross margin
- 69.6%
- Operating margin
- −2.4%
- Net margin
- −0.7%
Higher than 15% of US stocks
Higher than 26% of US stocks
Higher than 83% of US stocks
Higher than 32% of US stocks
Higher than 29% of US stocks
- Return on equity
- −5.0%
- Return on assets
- −0.2%
- Dividend yield
- 147.2%
Higher than 39% of US stocks
Higher than 42% of US stocks
Higher than 98% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
HHS vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HHS appears on the weeks it earns a place.
Frequently asked questions about HHS stock
Is HHS stock a buy right now?
Of the 1 analysts covering Harte-Hanks, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Harte-Hanks, Inc. 40 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank HHS?
As at 1 Aug 2026, Harte-Hanks, Inc. ranks 40 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (89 of 100).
What is the HHS stock forecast for 2030?
No analyst covering Harte-Hanks, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HHS are extrapolating price history, which says nothing about the business.
How has HHS stock performed over the past year?
Harte-Hanks, Inc. returned -41.3% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Harte-Hanks, Inc. do?
Harte-Hanks Inc. is a renowned marketing services company that specializes in multi-channel marketing solutions and customer interaction services.
About Harte-Hanks, Inc.
Harte-Hanks Inc. is a renowned marketing services company that specializes in multi-channel marketing solutions and customer interaction services. Its primary function is to assist businesses in achieving higher customer engagement and loyalty through innovative marketing strategies and data-driven insights. The company operates across various sectors, including retail, financial services, automotive, and healthcare, providing tailored solutions that enhance brand presence and performance. Harte-Hanks is noted for its ability to integrate traditional and digital marketing channels, offering services such as data management, analytics, customer care, and digital marketing. This versatility allows it to cater to a diverse clientele, addressing complex marketing challenges with precision and efficiency. In the financial market, Harte-Hanks plays a significant role by driving marketing transformation and empowering businesses with actionable intelligence. Its expertise in harnessing data to propel advertising campaigns is a valuable asset to companies navigating an increasingly competitive marketplace. Headquartered in the United States, Harte-Hanks continues to evolve, leveraging its rich history and expertise to remain at the forefront of the marketing services industry.
CEO Mr. Kirk A. Davis · 1,719 employees · United States · https://www.hartehanks.com